Rocket Comms is a full-service agency when it comes to PR and has helped us with a range of activities. From finding editorial opportunities, developing promotional ideas and events, to managing influencer campaigns, they are up to date on modern PR practices to help their clients achieve their goals. They have demonstrated their ability to work with a range of different stakeholders across our organisation, including managing sensitive topics on breast cancer with women who have this disease. What really makes Rocket Comms stand out from the crowd is that Rachel and her team genuinely care about people and how they they can help you tell your story to the right audiences.
ANNA FITZGERALD, BREAST CANCER TRIALS
RC has had the privilege to work with the incredible Breast Cancer Trials since 2018 when the organisation rebranded.
Breast Cancer Trials is the largest oncology research group in Australia and they have been responsible for most of the important advancements in breast cancer prevention and treatment, including the trials of Herceptin, Tamoxifen, Letrozole and Goserelin.
RC has been involved in promoting all aspects of Breast Cancer Trials operations from the announcements of new trials and results through to fundraising ideas and support.
To grow awareness of Breast Cancer Trials and their life-saving work; To position Breast Cancer Trials as the ‘go to’ for breast cancer treatment and prevention information; To increase funds raised.
Development of case study programme. Ongoing and timely expert and case study outreaches. Support trial announcements. Development and promotion of online Q&As. Help develop and promote innovative fundraising programmes. Create community of KOLs to extend promotion of Breast Cancer Trials work.
In addition to supporting the announcement of new open trials and results which often generate major national print and broadcast coverage, RC has also:
Breast Cancer Trials has continued to grow in every area: awareness and brand mentions in media and through influencer campaigns, as well as an increase in funds raised for the organisation.
In 2018, the media coverage generated for Breast Cancer Trials was just over 54 million with an advertising equivalent of just over $1million. In 2024, for media coverage alone (not including influencer activities), RC has generated a reach of over 1 billion.